StockData
Alnylam Pharmaceuticals, Inc. logo

Alnylam Pharmaceuticals, Inc. (ALNY) stock

ALNYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/3047% below fair value
$156.50−3.23 (-2.02%)

Close on Nov 17, 2026Market cap $20.96BP/E 8.1Yield –

How the market prices Alnylam Pharmaceuticals

Each ratio against its own distribution since 2016, from month-end prices and the figures reported at the time

Alnylam Pharmaceuticals trades at 4.2× its earnings, against a median of 25.7× since 2016 — cheaper than 100% of the months in between.

The shaded bar covers the 5th to 95th percentile of month-end values since 2016, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to sales since 2016

Median 25.7×, today 4.2×

What Alnylam Pharmaceuticals keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

Margins against the industry

Gross margin77.4%vs 52.8%
Operating margin19.5%vs -42.9%
EBITDA margin20.6%vs -29.3%
Pretax margin15.6%vs -13.0%
Net margin52.8%vs -39.9%
Free cash flow margin16.1%vs -9.41%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on equity126.6%vs -53.5%
Return on assets41.2%vs -40.7%
Return on capital employed16.5%vs -38.7%

How hard the assets work

Revenue per dollar of assets0.78vs 0.39
Inventory turns a year12.52vs 2.68
Revenue per employee$2.01Mvs $405.05K
Profit per employee$1.06Mvs -$704.12K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How fast it is growing

Trailing twelve months against a year earlier, and the compound annual rate over three and five fiscal years

Last 12 months3-year, a year5-year, a yearIndustry median

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Cash and short-term investments exceed every borrowing by $3.59B. That is 20.6% of the $17.37B it would cost to buy the business outright.

Cash and short-term investments$3.59B
EBITDA, trailing twelve months$1.03B
Free cash flow, trailing twelve months$806.31M

Leverage and liquidity

Current ratio2.48vs 3.28
Quick ratio2.26vs 2.37

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Altman Z-Score

Five ratios that together predicted bankruptcy within two years.

3.62
DistressGrey zoneSafe

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

6 of 9 tests passed

Beneish M-Score

Eight variables that flag accounts shaped to look better than they are.

-1.98
No flagManipulation risk

Price against two rules of thumb

Graham's number and Lynch's fair value, both derived from current earnings.

Graham $107.98Price $156.50

What comes back to shareholders

Trailing twelve months against the market value at the latest close

Earnings yield12.6%vs -22.8%
Free cash flow yield3.85%vs -9.68%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How the shares have traded

Total return includes reinvested dividends, to the close on Nov 17, 2026

$149.1852-week low52-week high$479.79
$156.5020-day50-day200-day

The close sits 2% of the way up the 52-week range, 67.4% below the high.

Relative strength index, 14 days

How much of the recent move has been upward. Extremes are where traders look for a turn.

31
OversoldNeutralOverbought

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

ALNYS&P 500
PeriodALNYS&P 500DifferenceALNY per yearS&P 500 per year
1 month-32.5%-4.0%−28.5 pts
3 months-30.3%-5.0%−25.3 pts
Year to date-60.6%+8.2%−68.9 pts
1 year-66.0%+11.2%−77.2 pts
3 years-4.4%+68.5%−72.9 pts-1.5%+19.0%
5 years-9.4%+67.3%−76.7 pts-2.0%+10.8%
10 years+237.6%+291.6%−54.1 pts+12.9%+14.6%

How much it moves

Volatility, 1 year54.6%vs 80.5%
Volume against its 90-day average0.99vs 0.86

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

5M ALNY shares were sold short on Oct 30, 2026, down 16.8% from the previous report, or 4.10% of the shares available to trade. At recent volumes it would take 1.9 days to buy them back. Over the last 20 sessions, 23.1% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover
Short interest as a share of the float4.10%vs 8.89%
Short interest as a share of all shares4.08%vs 6.30%
Days of volume to buy it back1.91vs 5.13

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20265,465,979-16.8%2,867,3991.9
Oct 15, 20266,568,786-14.8%1,289,1275.1
Sep 30, 20267,711,495+7.2%1,195,1076.5
Sep 15, 20267,194,097+13.5%1,742,2344.1
Aug 31, 20266,340,087+32.9%1,625,5743.9
Aug 14, 20264,770,978-0.7%2,018,3992.4
Jul 31, 20264,803,194-16.8%2,204,4462.2
Jul 15, 20265,773,373-0.5%1,782,4773.2
Jun 30, 20265,799,788+6.7%1,373,0854.2
Jun 15, 20265,437,337+2.6%1,142,7124.8
May 29, 20265,300,015-1.8%917,6375.8
May 15, 20265,398,804+13.1%1,052,0115.1

Every measure, in full

95 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Feb 11, 2027 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 17, 2026

Valuation ratiosIndustry

Market Cap
$20.96B
$254.69M
Enterprise Value
$17.37B
$130.88M
PE Ratio
8.13
23.02
PS Ratio
4.18
3.66
PB Ratio
5.82
1.99
P/TBV Ratio
5.82
2.23
P/FCF Ratio
26.00
18.54
P/OCF Ratio
21.93
13.24

Enterprise valuationIndustry

EV / Sales
3.47
2.38
EV / EBITDA
16.82
16.00
EV / EBIT
17.77
18.86
EV / FCF
21.55
21.55

Share statisticsIndustry

Shares Change (YoY)
4.57%
11.0%
Shares Change (QoQ)
0.11%
0.57%
Float
133M
49M
Shares Held by Insiders
0.49%
11.3%
Shares Held by Institutions
99.7%
56.3%

Short sellingIndustry

Short Interest
5M
–
Short Interest Change
-16.8%
-0.80%
Short % of Float
4.10%
8.89%
Short % of Shares Outstanding
4.08%
6.30%
Days to Cover
1.91
5.13

Stock price statisticsIndustry

52-Week High
$479.79
–
52-Week Low
$149.18
–
20-Day Moving Average
$179.99
–
50-Day Moving Average
$215.05
–
200-Day Moving Average
$273.68
–
Average True Range (14)
$9.98
–
Price Change (1 Week)
3.20%
-7.83%
Price Change (1 Month)
-32.9%
-6.48%
Price Change (3 Months)
-35.5%
-26.6%
Price Change (6 Months)
-46.8%
-22.2%
Price Change (YTD)
-60.6%
-25.6%
Price Change (1 Year)
-65.2%
-23.8%
Price Change (3 Years)
-4.42%
-32.9%
Price Change (5 Years)
-12.6%
-77.3%
Price Change (10 Years)
240.4%
-66.7%
Average Volume (10 Days)
3M
–
Average Volume (20 Days)
3M
–
Average Volume (90 Days)
2M
–
Relative Volume
0.99
0.86
Relative Strength Index (14)
31.2
40.3
Volatility (1 Year)
54.6%
80.5%

MarginsIndustry

Gross Margin
77.4%
52.8%
Operating Margin
19.5%
-42.9%
Pretax Margin
15.6%
-13.0%
Profit Margin
52.8%
-39.9%
EBITDA Margin
20.6%
-29.3%
FCF Margin
16.1%
-9.41%

Returns on capitalIndustry

Return on Equity (ROE)
126.6%
-53.5%
Return on Assets (ROA)
41.2%
-40.7%
Return on Capital Employed (ROCE)
16.5%
-38.7%

Financial positionIndustry

Current Ratio
2.48
3.28
Quick Ratio
2.26
2.37
Interest Coverage
3.25
-6.20

GrowthIndustry

Revenue Growth (YoY)
56.2%
5.68%
Net Income Growth (YoY)
2136.9%
-31.1%
EPS Growth (YoY)
2307.5%
-25.8%
FCF Growth (YoY)
382.3%
3.26%
Revenue Growth (3Y CAGR)
53.0%
2.25%
Revenue Growth (5Y CAGR)
49.8%
6.41%

EfficiencyIndustry

Asset Turnover
0.78
0.39
Inventory Turnover
12.52
2.68
Revenue Per Employee
$2.01M
$405.05K
Profits Per Employee
$1.06M
-$704.12K
Employee Count
2,500
75

Income statement (TTM)Industry

Revenue
$5.01B
$58.79M
Gross Profit
$3.88B
$103.58M
Operating Income
$977.59M
-$21.49M
Pretax Income
$781.53M
-$14.83M
Net Income
$2.65B
-$22.47M
EBITDA
$1.03B
-$17.14M
EPS (Diluted)
$19.26
-$0.83

Balance sheetIndustry

Net Cash (Debt)
$3.59B
$15.31M
Net Cash Per Share
$26.78
$0.72
Equity (Book Value)
$3.60B
$49.40M
Book Value Per Share
$26.91
$1.45
Tangible Book Value
$3.60B
$23.58M
Working Capital
$3.05B
$74.34M

Cash flow (TTM)Industry

Operating Cash Flow
$955.94M
-$12.17M
Capital Expenditures
-$149.64M
-$1.02M
Free Cash Flow
$806.31M
-$20.44M
FCF Per Share
$6.02
-$0.42

Dividends and yieldsIndustry

Earnings Yield
12.6%
-22.8%
FCF Yield
3.85%
-9.68%

Taxes and interestIndustry

Interest Expense
$301.11M
$3.07M
Income Tax
-$1.87B
$77.43K
Effective Tax Rate
-239.0%
20.7%

Scores and fair valueIndustry

Graham Number
$107.98
$19.07
Graham Upside
-31.0%
-47.6%
Altman Z-Score
3.62
0.12
Piotroski F-Score
6
4
Beneish M-Score
-1.98
-2.62

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?